SORT1 enhancer independent-library replicate saturation-mutagenesis MPRA
An independently constructed 600-bp SORT1 enhancer saturation-mutagenesis library was tested in HepG2 human hepatoblastoma cells 24 hours after plasmid transfection.
Martin Kircher, Chenling Xiong, Beth Martin, Max Schubach, Fumitaka Inoue et al.
The majority of common variants associated with common diseases, as well as an unknown proportion of causal mutations for rare diseases, fall in noncoding regions of the genome. Although catalogs of noncoding regulatory elements are steadily improving, we have a limited understanding of the functional effects of mutations within them. Here, we perform saturation mutagenesis in conjunction with massively parallel reporter assays on 20 disease-associated gene promoters and enhancers, generating functional measurements for over 30,000 single nucleotide substitutions and deletions. We find that the density of putative transcription factor binding sites varies widely between regulatory elements, as does the extent to which evolutionary conservation or integrative scores predict functional effects. These data provide a powerful resource for interpreting the pathogenicity of clinically observed mutations in these disease-associated regulatory elements, and comprise a rich dataset for the further development of algorithms that aim to predict the regulatory effects of noncoding mutations.
Martin Kircher, Chenling Xiong, Beth Martin, Max Schubach, Fumitaka Inoue, Robert J. A. Bell, Joseph F. Costello, Jay Shendure, Nadav Ahituv. Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution. 2019-08-08. https://doi.org/10.1038/s41467-019-11526-w
An independently constructed 600-bp SORT1 enhancer saturation-mutagenesis library was tested in HepG2 human hepatoblastoma cells 24 hours after plasmid transfection.
A reverse-orientation 600-bp SORT1 enhancer saturation-mutagenesis library was tested in HepG2 human hepatoblastoma cells 24 hours after plasmid transfection.
A 259-bp cancer-associated TERT promoter saturation-mutagenesis library was tested in HEK293T human embryonic-kidney cells 24 hours after plasmid transfection.
A 259-bp cancer-associated TERT promoter saturation-mutagenesis library was tested in primary human glioblastoma cell line SF7996 24 hours after plasmid transfection.
A 485-bp human limb-specific ZRS enhancer library was tested in mouse NIH/3T3 fibroblasts with HOXD13 co-transfection.
A 600-bp cleft-lip-associated IRF6 enhancer library was tested in HaCaT human keratinocytes 24 hours after plasmid transfection.
A 187-bp beta-thalassemia-associated HBB promoter library was tested in HEL 92.1.7 human erythroblast cells 24 hours after plasmid transfection.
A 318-bp familial-hypercholesterolemia-associated LDLR promoter library was tested in HepG2 human hepatoblastoma cells 24 hours after plasmid transfection.
The same 470-bp PKLR promoter saturation-mutagenesis library was tested in K562 human erythroleukemia cells and harvested 48 hours after plasmid transfection.
A 470-bp pyruvate-kinase-deficiency-associated PKLR promoter library was tested in K562 human erythroleukemia cells and harvested 24 hours after plasmid transfection.
A 600-bp plasma-LDL and myocardial-infarction-associated SORT1 enhancer library was tested in HepG2 human hepatoblastoma cells 24 hours after plasmid transfection.
An independently constructed 318-bp LDLR promoter saturation-mutagenesis library was tested in HepG2 human hepatoblastoma cells 24 hours after plasmid transfection.
The 259-bp TERT promoter saturation-mutagenesis library was assayed in SF7996 primary human glioblastoma cells after scramble-siRNA control treatment and 24 hours of reporter-library transfection.
The 259-bp TERT promoter saturation-mutagenesis library was assayed in SF7996 primary human glioblastoma cells after siGABPA treatment and 24 hours of reporter-library transfection.
A 600-bp sickle-cell-disease-associated BCL11A +58 enhancer library was tested in HEL 92.1.7 human erythroblast cells 24 hours after plasmid transfection.
A 285-bp maturity-onset diabetes-associated HNF4A P2 promoter library was tested in HEK293T human embryonic-kidney cells 24 hours after plasmid transfection.
A 485-bp human limb-specific ZRS enhancer library was tested in mouse NIH/3T3 fibroblasts with HOXD13 and HAND2 co-transfection.
A 590-bp ultraconserved enhancer (UC88) library was tested in mouse Neuro-2a neuroblastoma cells 24 hours after plasmid transfection; UC88 was not selected for a disease phenotype.
A 464-bp MYC rs11986220-associated enhancer library was tested in LNCaP human prostate cancer cells with 100 nM dihydrotestosterone.
A 451-bp human-pigmentation-associated IRF4 enhancer library was tested in SK-MEL-28 human melanoma cells 24 hours after plasmid transfection.
A 600-bp type-2-diabetes-associated TCF7L2 enhancer library was tested in mouse MIN6 pancreatic beta cells 24 hours after plasmid transfection.
A 274-bp hereditary-persistence-of-fetal-hemoglobin-associated HBG1 promoter library was tested in HEL 92.1.7 human erythroblast cells 24 hours after plasmid transfection.
A 600-bp thyroid-cancer-associated FOXE1 promoter library was tested in HeLa human cervical cancer cells with USF1 and USF2 co-transfection.
A 303-bp hemophilia B-associated F9 promoter library was tested in HepG2 human hepatoblastoma cells 24 hours after plasmid transfection.
A 593-bp prostate-cancer-associated MSMB promoter library was tested in HEK293T human embryonic-kidney cells 24 hours after plasmid transfection.
A 385-bp Bernard–Soulier-syndrome-associated GP1BB promoter library was tested in HEL 92.1.7 human erythroblast cells 24 hours after plasmid transfection.
A 579-bp type-2-diabetes-associated ZFAND3 enhancer library was tested in mouse MIN6 pancreatic beta cells 24 hours after plasmid transfection.
A 600-bp Hirschsprung-disease-associated RET enhancer library was tested in mouse Neuro-2a neuroblastoma cells 24 hours after plasmid transfection.
A 600-bp MYC rs6983267-associated enhancer library was tested in HEK293T human embryonic-kidney cells; 20 nM LiCl was added after 24 hours and cells were harvested at 32 hours.
Original supplemental and deposited inputs retained for this study. Download files individually or together as a ZIP; nested folders are preserved. Source reuse terms apply, and sequencing reads may be omitted.
Download all 35 files (ZIP)geo_filelist.txtGSE126550_family.soft.gzosf_effect_tables/GRCh37_BCL11A.tsvosf_effect_tables/GRCh37_F9.tsvosf_effect_tables/GRCh37_FOXE1.tsvosf_effect_tables/GRCh37_GP1BA.tsvosf_effect_tables/GRCh37_HBB.tsvosf_effect_tables/GRCh37_HBG1.tsvosf_effect_tables/GRCh37_HNF4A.tsvosf_effect_tables/GRCh37_IRF4.tsvosf_effect_tables/GRCh37_IRF6.tsvosf_effect_tables/GRCh37_LDLR.2.tsvosf_effect_tables/GRCh37_LDLR.tsvosf_effect_tables/GRCh37_MSMB.tsvosf_effect_tables/GRCh37_MYCrs11986220.tsvosf_effect_tables/GRCh37_MYCrs6983267.tsvosf_effect_tables/GRCh37_PKLR-24h.tsvosf_effect_tables/GRCh37_PKLR-48h.tsvosf_effect_tables/GRCh37_RET.tsvosf_effect_tables/GRCh37_SORT1-flip.tsvosf_effect_tables/GRCh37_SORT1.2.tsvosf_effect_tables/GRCh37_SORT1.tsvosf_effect_tables/GRCh37_TCF7L2.tsvosf_effect_tables/GRCh37_TERT-GAa.tsvosf_effect_tables/GRCh37_TERT-GBM.tsvosf_effect_tables/GRCh37_TERT-GSc.tsvosf_effect_tables/GRCh37_TERT-HEK.tsvosf_effect_tables/GRCh37_UC88.tsvosf_effect_tables/GRCh37_ZFAND3.tsvosf_effect_tables/GRCh37_ZRSh-13.tsvosf_effect_tables/GRCh37_ZRSh-13h2.tsvREADME.mdsource_manifest.tsvsupplementary_information.pdfsupplementary_information.txt